Home › Compare › PMSNF vs RYLD

PMSNF vs RYLD: Dividend Comparison 2026

PMSNF yields 10000.00% · RYLD yields 12.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PMSNF wins by $55137509079256512.00M in total portfolio value
10 years
PMSNF
PMSNF
● Live price
10000.00%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$55137509079256512.00M
Annual income
$54,073,795,673,722,890,000,000.00
Full PMSNF calculator →
RYLD
RYLD
● Live price
12.14%
Share price
$14.95
Annual div
$1.81
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.5K
Annual income
$2,587.35
Full RYLD calculator →

Portfolio growth — PMSNF vs RYLD

📍 PMSNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPMSNFRYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PMSNF + RYLD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
PMSNF pays
RYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PMSNF
Annual income on $10K today (after 15% tax)
$850,000.00/yr
After 10yr DRIP, annual income (after tax)
$45,962,726,322,664,450,000,000.00/yr
RYLD
Annual income on $10K today (after 15% tax)
$1,031.60/yr
After 10yr DRIP, annual income (after tax)
$2,199.25/yr
At 15% tax rate, PMSNF beats the other by $45,962,726,322,664,450,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PMSNF + RYLD for your $10,000?

PMSNF: 50%RYLD: 50%
100% RYLD50/50100% PMSNF
Portfolio after 10yr
$27568754539628256.00M
Annual income
$27,036,897,836,861,443,000,000.00/yr
Blended yield
98.07%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PMSNF buys
0
RYLD buys
0
No recent congressional trades found for PMSNF or RYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPMSNFRYLD
Forward yield10000.00% ✓12.14%
Annual dividend / share$2.00 ✓$1.81
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$55137509079256512.00M ✓$44.5K
Annual income after 10y$54,073,795,673,722,890,000,000.00 ✓$2,587.35
Total dividends collected$55066727460582336.00M ✓$18.8K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: PMSNF vs RYLD ($10,000, DRIP)

YearPMSNF PortfolioPMSNF Income/yrRYLD PortfolioRYLD Income/yrGap
1← crossover$1,010,700$1,000,000.00$11,914$1,213.65+$998.8K → PMSNF
2$95,539,393$94,457,943.93$14,099$1,351.30+$95.53M → PMSNF
3$8,447,007,736$8,344,780,585.66$16,580$1,494.55+$8446.99M → PMSNF
4$698,565,746,383$689,527,448,105.17$19,384$1,642.61+$698565.73M → PMSNF
5$54,040,711,670,213$53,293,246,321,583.74$22,535$1,794.70+$54040711.65M → PMSNF
6$3,910,851,616,519,516$3,853,028,055,032,387.00$26,063$1,950.00+$3910851616.49M → PMSNF
7$264,781,167,546,477,440$260,596,556,316,801,570.00$29,995$2,107.69+$264781167546.45M → PMSNF
8$16,772,556,223,821,672,000$16,489,240,374,546,942,000.00$34,361$2,266.99+$16772556223821.64M → PMSNF
9$994,124,678,068,810,000,000$976,178,042,909,320,800,000.00$39,194$2,427.12+$994124678068810.00M → PMSNF
10$55,137,509,079,256,515,000,000$54,073,795,673,722,890,000,000.00$44,525$2,587.35+$55137509079256512.00M → PMSNF

PMSNF vs RYLD: Complete Analysis 2026

PMSNF — Stock

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, and European Union. The company offers SysQuant provides comprehensive analysis of protein activity across regulatory and signaling pathways; TMT MS2 for analyzing cells and tissues when no phosphopeptide enrichment is required; and TMT MS3, a method for biomarker discovery in plasma and other complex samples where quantitative accuracy is the important factor. It also provides TMT Calibrator that analyzes diseased or treated tissue in parallel with peripheral fluids; TMT SRM, a targeted assay format that enables the rapid validation of biomarker candidates; and SRM assay, a targeted mass spectrometry assay format for the routine measurement of biomarkers. In addition, the company offers bioinformatics tools, including Proteome Discoverer for peptide sequence and TMT quantitation; SQuaT,CalDIT, and DIANA for normalized quantitative values and functional annotation at peptide and protein level; FeaST for visualization of data quality, class identifier model, and biomarker candidate lists; and FAT for identification of biological processes and cellular components showing variance. It primarily serves pharmaceutical and biotechnology companies, and academic research institutes. The company was incorporated in 1993 and is based in Cobham, the United Kingdom.

Full PMSNF Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →
📬

Get this PMSNF vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PMSNF vs SCHDPMSNF vs JEPIPMSNF vs OPMSNF vs KOPMSNF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.